GHK-Cu

Naturally occurring copper tripeptide that modulates 4,000+ genes. Proven efficacy for skin rejuvenation, wound healing, and tissue remodeling. Declines with age.

Normal Protocol

Advanced Protocol

Overview

Also Known As

Copper Peptide, Glycyl-L-Histidyl-L-Lysine:Copper(II), Copper Tripeptide-1, Prezatide Copper Acetate

Mechanism of Action

Modulates 4,000+ genes (~6% of genome). Stimulates collagen I/III synthesis, decorin, and GAG production. Delivers bioavailable copper for lysyl oxidase, SOD, and cytochrome c oxidase. Anti-inflammatory via TGF-β/TNF-α suppression. Stimulates VEGF for angiogenesis.

Product

Copper Peptide, Glycyl-L-Histidyl-L-Lysine:Copper(II), Copper Tripeptide-1, Prezatide Copper Acetate vial
Dosing & Administration
Typical protocols and routes

Half-Life

Plasma: relatively short. Topical: sustained local effects over hours. Copper-peptide complex is stable.

Administration Routes

topicalsubcutaneous

Dosing Protocols

Average: reconstitute 50 mg vial with 2.5 mL bacteriostatic water, draw 10 units on insulin syringe (marked 1-100). Only one recommended dose level for this peptide. Advanced (Glow Blend): reconstitute with 1 mL bacteriostatic water, draw 10 units daily (vial lasts 10 days).
Research
Key findings and status

Key Research Findings

Leyden et al. (2002): RCT showing improved skin laxity, clarity, fine lines vs placebo. Canapp et al. (2003): 44% wound closure vs 22% control. Pickart & Margolina (2018): gene expression reversal in cancer/COPD cell lines. Broad Institute Connectivity Map: top compound for reversing age-related gene changes.
Detailed Information

GHK-Cu (copper peptide GHK-Cu, or glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. First identified by Loren Pickart in 1973 from human albumin, GHK-Cu has become one of the most extensively studied peptides in regenerative medicine and cosmetic science, with over 60 years of cumulative research.

Mechanism of Action

GHK-Cu is a pleiotropic signaling molecule that modulates the expression of over 4,000 human genes — approximately 6% of the human genome. Its primary biological functions center on tissue remodeling: it stimulates collagen synthesis (types I and III), promotes decorin production, increases glycosaminoglycan synthesis, and activates metalloproteinase pathways for controlled tissue remodeling.

The copper ion is essential to its activity. GHK-Cu delivers bioavailable copper to cells, which is required for the function of lysyl oxidase (collagen and elastin crosslinking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (mitochondrial function). Additionally, GHK-Cu has potent anti-inflammatory effects, suppressing TGF-β and TNF-α while stimulating VEGF for angiogenesis.

GHK-Cu concentration in plasma declines with age: approximately 200 ng/mL at age 20, declining to 80 ng/mL by age 60. This age-related decline correlates with reduced tissue repair capacity.

Research Evidence

Pickart et al. have published extensively demonstrating GHK-Cu efficacy for wound healing and skin regeneration. Leyden et al. (2002) conducted a placebo-controlled clinical trial showing GHK-Cu cream significantly improved skin laxity, clarity, and firmness while reducing fine lines and wrinkles versus placebo after 12 weeks.

Canapp et al. (2003) demonstrated that GHK-Cu accelerated wound healing with 44% wound closure at day 12 versus 22% in controls. Gene expression studies (Pickart and Margolina, 2018) identified that GHK-Cu reverses the gene expression signature of COPD, metastatic colon cancer, and aggressive prostate cancer cell lines toward a healthier profile, suggesting systemic regenerative potential beyond cosmetic applications.

The Broad Institute Connectivity Map project independently identified GHK as one of the compounds that most effectively reverses age-related gene expression changes.

Safety & Legal

Side Effects & Warnings

Topical: generally very well-tolerated. Rare: mild irritation in sensitive skin. May temporarily increase skin sensitivity to sun. Systemic: limited data, but as an endogenous compound, theoretical safety profile is favorable. Copper excess possible with very high systemic doses.

Legal Status

Available over-the-counter in cosmetic products. Injectable form available as research peptide.
Molecular Data
Chemical properties

Molecular Weight

403.93 g/mol (copper complex)

Amino Acid Sequence

Gly-His-Lys:Cu²⁺

Quick Facts

Class

Cosmetic

Research Status

Clinical Trials

Half-Life

Plasma: relatively short. Topical: sustained local effects over hours. Copper-peptide complex is stable.

Routes

topical
subcutaneous

Category

Skin & Cosmetic Peptides